Accessibility helpSkip to navigationSkip to contentSkip to footer

Cookies on FT Sites

We use cookies for a number of reasons, such as keeping FT Sites reliable and secure, personalising content and ads, providing social media features and to analyse how our Sites are used.

Accept & continue
Manage cookies
  • Sign In
  • Subscribe
Open side navigation menuOpen search bar
Financial Times
SubscribeSign InmyFT
  • Home
  • World
    Sections
    • World Home
    • Global Economy
    • UK
    • US
    • China
    • Africa
    • Asia Pacific
    • Emerging Markets
    • Europe
    • War in Ukraine
    • Americas
    • Middle East & North Africa
    • Australia & NZ
    Most Read
    • Boris Johnson on the brink after Rishi Sunak and Sajid Javid quit UK cabinet
    • Nadhim Zahawi: rapid rise of Britain’s new chancellor
    • Nadhim Zahawi to review corporation tax rise as Boris Johnson battles to stay in office
    • Congo’s president Félix Tshisekedi warns of risk of war with Rwanda
    • Cabinet ministers call on Boris Johnson to quit
  • US
    Sections
    • US Home
    • US Economy
    • US Companies
    • US Politics & Policy
    Most Read
    • Crypto collapse reverberates widely among black American investors
    • US bond market flashes warning signal of economic slowdown
    • Facebook owner Meta to push ahead with digital collectibles plan
    • Oil prices turn sharply lower on fears recession will undercut demand
    • America’s unending horizon of mass shootings
  • Companies
    Sections
    • Companies Home
    • Energy
    • Financials
    • Health
    • Industrials
    • Media
    • Professional Services
    • Retail & Consumer
    • Tech Sector
    • Telecoms
    • Transport
    Most Read
    • Property set to cool as investors face ‘new paradigm’, Brookfield warns
    • Warren Buffett-backed Chinese group BYD overtakes Tesla in global electric vehicle sales
    • BA flight cancellations and refuelling strikes set to bring more travel chaos
    • KPMG’s business in UAE split by partner infighting and coup attempt
    • EY boosts accountancy title inflation by dubbing senior staff ‘partner’
  • Tech
  • Markets
    Sections
    • Markets Home
    • Alphaville
    • Markets Data
    • Capital Markets
    • Commodities
    • Currencies
    • Equities
    • Fund Management
    • Trading
    • Moral Money
    • ETF Hub
    • Cryptocurrencies
    Most Read
    • Live news updates: Senior cabinet ministers to tell Johnson to quit as UK prime minister
    • US bond market flashes warning signal of economic slowdown
    • ECB’s crisis-fighting scheme risks being tied up in legal and political knots
    • The stock market still has high hopes
    • Pound traders look past UK political turmoil
  • Climate
  • Opinion
    Sections
    • Opinion Home
    • Columnists
    • The FT View
    • The Big Read
    • Lex
    • Obituaries
    • Letters
    Most Read
    • This is the endgame for Boris Johnson — but it may not be quick
    • Cryptocurrencies are not the new monetary system we need
    • America’s unending horizon of mass shootings
    • Supreme Court EPA ruling puts regulators in handcuffs
    • The stock market still has high hopes
  • Work & Careers
    Sections
    • Work & Careers Home
    • Business School Rankings
    • Business Education
    • Entrepreneurship
    • Recruitment
    • Business Books
    • Business Travel
    Most Read
    • Michael Lewis: ‘The thing that really works for Trump is: the system’s rigged’
    • Meet the founders with the boomerang factor
    • British Rail: A New History — a timely reminder of how to run a railway
    • Pop-up leaders and flexible staff are ready for a new crisis
    • Help truly wanted, even if you’ve been in jail
  • Life & Arts
    Sections
    • Life & Arts Home
    • Arts
    • Books
    • Food & Drink
    • FT Magazine
    • House & Home
    • Style
    • Travel
    • FT Globetrotter
    Most Read
    • Chess: Nepo wins Candidates again as Carlsen asks for new world title format
    • Galápagos now: when a superyacht meets world heritage site
    • Worth a shot: 10 intriguing new tennis gadgets
    • Postcard from Norfolk: the churches marooned behind army lines
    • Swimsuits to make a splash in 
  • HTSI
MenuSearch
  • Home
  • World
  • US
  • Companies
  • Tech
  • Markets
  • Climate
  • Opinion
  • Work & Careers
  • Life & Arts
  • HTSI
Financial Times
SubscribeSign In

Your guide to a disrupted world

Start a 4-week trial

Coronavirus treatment

Add to myFT Digest

Add this topic to your myFT Digest for news straight to your inbox

  • Tuesday, 5 July, 2022
    CureVac GmbH
    CureVac sues BioNTech over mRNA patents

    Pharma group seeks compensation from Covid vaccine maker for alleged IP infringements

  • Sunday, 3 July, 2022
    Covid-19 vaccines
    Covid vaccines: how can immune imprinting help experts to rethink jabs?

    More than two years into the pandemic, people have acquired different levels of immunity through infections and shots

  • Friday, 1 July, 2022
    Covid-19 vaccines
    Oxford BioMedica extends Covid vaccine deal with AstraZeneca

    New three-year contract in place if UK drugmaker continues to manufacture the jab

  • Wednesday, 29 June, 2022
    Q&ACoronavirus pandemic
    How worried should we be about new Covid variants?

    FT science editor Clive Cookson and global pharma correspondent Hannah Kuchler answered your questions about rising Omicron infections and vaccine efficiency

  • Tuesday, 28 June, 2022
    Covid-19 vaccines
    FDA panel recommends redesigning Covid vaccine to target Omicron variant

    Change would incorporate genetic material from fast-spreading strain in new boosters

  • Tuesday, 28 June, 2022
    Anjana Ahuja
    Monkeypox makes pledges of pandemic solidarity look hollow

    The global south has once again been abandoned in its quest for vaccines

  • Monday, 27 June, 2022
    Covid-19 vaccines
    Pause in medication would improve Covid jab response for millions, study shows

    Short break in immune suppression treatment improves antibody production after vaccination while doing little harm

  • Saturday, 25 June, 2022
    Covid-19 vaccines
    BioNTech/Pfizer say Omicron-targeting boosters elicit strong immune response

    New vaccine candidates significantly outperform existing Covid jabs at targeting the most prevalent strain

  • Friday, 24 June, 2022
    Disrupted Times
    Pandemics don’t have neat endings

    UK surge in infection rates, US faces recession, give women their Wimbledon due

  • Friday, 24 June, 2022
    The FT ViewThe editorial board
    Living with Covid-19 requires caution, not complacency

    Governments need to plan now for what could be a tough autumn

  • Friday, 24 June, 2022
    Covid-19 vaccines
    Sanofi-GSK Covid vaccine found effective against Omicron

    Pharma companies are hoping to catch up with rivals as they report promising trial results for jab

  • Thursday, 23 June, 2022
    Covid-19 vaccines
    Covid vaccines prevented 20mn deaths globally, study finds

    Mathematical modelling looked at deaths directly and indirectly linked to jabs

  • Thursday, 23 June, 2022
    UK prepares to include over-50s in autumn Covid booster campaign

    Javid says he asked officials to revise previous plans that would exclude under-65s

  • Wednesday, 22 June, 2022
    Medical science
    Poliovirus detected in London sewage samples

    UK health agency investigating possibility of community transmission says risk to public ‘extremely low’

  • Wednesday, 22 June, 2022
    Moderna
    Moderna calls for approval of two-strain Covid vaccine booster

    US biotech group says shot targeting both first strain and Omicron could help avert ‘large rise’ in cases

  • Wednesday, 22 June, 2022
    Covid-19 vaccines
    UK signs £1bn deal with Moderna for new vaccine centre

    Government seeks to secure domestic jab supply and prepare for future pandemics in deal with Boston biotech

  • Monday, 20 June, 2022
    Uhuru Kenyatta
    President Kenyatta: We need vaccines and investment to tip the scales against malaria

    After years in retreat, the disease is once again on the rise across the continent

  • Saturday, 18 June, 2022
    Covid-19 vaccines
    US CDC recommends Covid vaccines for children under 5

    Children as young as six months old can begin receiving Pfizer or Moderna vaccines as soon as Monday

  • Saturday, 18 June, 2022
    Covid-19 vaccines
    BioNTech chief calls for speedy ruling on Covid vaccines that target latest strains

    ‘Time is ticking’ as studies suggest original Omicron jabs may not offer strong protection against sub-variants

  • Thursday, 16 June, 2022
    Covid-19 vaccines
    WHO set to back use of Covid variant-specific vaccines as third shot

    Recommendation by health agency advisory group marks shift in thinking of global health authorities

  • Thursday, 16 June, 2022
    Special ReportEurope’s Leading Patent Law Firms
    Nations urged to waive vaccine patents while drugmakers say rules are fair

    Only 1 per cent of the 10bn jabs delivered so far have been in low-income countries

  • Wednesday, 15 June, 2022
    Covid-19 vaccines
    FDA advisory panel backs Covid-19 vaccines for children under 5

    US prepares to roll out jabs to last age group without access once regulatory approval is received

  • Tuesday, 14 June, 2022
    Global trade
    India attacks rich countries over vaccine charges and fishing

    Commerce minister’s surprise remarks put WTO agreements at risk

  • Tuesday, 14 June, 2022
    OutlookGideon Long
    Summit of Americas proves the growing irrelevance of such gatherings

    At last week’s conference in LA, the real activity was outside on the streets

  • Tuesday, 14 June, 2022
    The Big Read
    BioNTech’s second act: can it transform the fight against cancer?

    The German company is ploughing Covid vaccine profits into oncology but its technology is still largely unproven

Previous page You are on page 1 Next page

Recommended

Covid-19 vaccines
Covid-19 vaccine tracker: Lowest-income countries lag further behind rest of the world
Covid-19 vaccines
Covid vaccine development: The shots available and the doses administered
Covid-19 vaccines
In graphics: the UK vaccine supply chain
Coronavirus: free to read
Coronavirus tracker: the latest figures as countries fight the Covid-19 resurgence

Useful links

Support

View Site TipsHelp CentreContact UsAbout UsAccessibilitymyFT TourCareers

Legal & Privacy

Terms & ConditionsPrivacy PolicyCookiesCopyrightSlavery Statement & Policies

Services

Share News Tips SecurelyIndividual SubscriptionsGroup SubscriptionsRepublishingExecutive Job SearchAdvertise with the FTFollow the FT on TwitterFT ChannelsSecondary Schools

Tools

PortfolioToday's Newspaper (ePaper)Alerts HubBusiness School RankingsEnterprise ToolsNews feedNewslettersCurrency Converter

Community & Events

FT CommunityFT LiveFT ForumsFT Board DirectorBoard Director Programme

More from the FT Group

Markets data delayed by at least 15 minutes. © THE FINANCIAL TIMES LTD 2022. FT and ‘Financial Times’ are trademarks of The Financial Times Ltd.
The Financial Times and its journalism are subject to a self-regulation regime under the FT Editorial Code of Practice.
Financial Times

International Edition

Subscribe for full access
  • Switch to UK Edition
  • Top sections
  • Home
  • World
    • Global Economy
    • UK
    • US
    • China
    • Africa
    • Asia Pacific
    • Emerging Markets
    • Europe
    • War in Ukraine
    • Americas
    • Middle East & North Africa
    • Australia & NZ
  • US
    • US Economy
    • US Companies
    • US Politics & Policy
  • Companies
    • Energy
    • Financials
    • Health
    • Industrials
    • Media
    • Professional Services
    • Retail & Consumer
    • Tech Sector
    • Telecoms
    • Transport
  • Tech
  • Markets
    • Alphaville
    • Markets Data
    • Capital Markets
    • Commodities
    • Currencies
    • Equities
    • Fund Management
    • Trading
    • Moral Money
    • ETF Hub
    • Cryptocurrencies
  • Climate
  • Opinion
    • Columnists
    • The FT View
    • The Big Read
    • Lex
    • Obituaries
    • Letters
  • Work & Careers
    • Business School Rankings
    • Business Education
    • Entrepreneurship
    • Recruitment
    • Business Books
    • Business Travel
  • Life & Arts
    • Arts
    • Books
    • Food & Drink
    • FT Magazine
    • House & Home
    • Style
    • Travel
    • FT Globetrotter
  • Personal Finance
    • Property & Mortgages
    • Investments
    • Pensions
    • Tax
    • Banking & Savings
    • Advice & Comment
    • Next Act
  • HTSI
  • Special Reports
  • FT recommends
  • Lex
  • Alphaville
  • Lunch with the FT
  • FT Globetrotter
  • #techAsia
  • Moral Money
  • FTfm
  • Newsletters
  • Video
  • Podcasts
  • News feed
  • FT Community
    • FT Live
    • FT Forums
    • Board Director Programme
  • myFT
  • Portfolio
  • Today's Newspaper (ePaper)
  • Crossword
  • Our Apps
  • Help Centre
  • Subscribe
  • Sign In